Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium voltage-gated channel subfamily Q member 3 (KCNQ3) is a pore-forming subunit of voltage-gated potassium channels, specifically M-channels. It plays a crucial role in regulating neuronal excitability by transporting potassium ions out of cells and transmitting the M-current, which acts as a brake on neuronal activity. Mutations in KCNQ3 are associated with neurological disorders such as benign familial neonatal seizures.
Voltage-gated potassium channel modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily Q member 3 (KCNQ3).